论文部分内容阅读
目的评价哌拉西林钠/他唑巴坦钠治疗慢性阻塞性肺疾病急性加重期的疗效。方法将41例慢性阻塞性肺疾病急性加重患者常规治疗基础上应用哌拉西林钠/他唑巴坦钠针剂3.375g(每支1.125g),每8h静脉滴注,疗程7～10d。结果临床有效率95.12%,细菌清除率92.5%。结论哌拉西林钠/他唑巴坦钠治疗慢性阻塞性肺疾病急性加重的疗效显著。
Objective To evaluate the efficacy of piperacillin / tazobactam in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods A total of 41 patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) were given routine treatment with 3.375g of piperacillin / tazobactam sodium injection (1.125g each), and the drug was infused every 8h for 7-10 days. Results The clinical effective rate was 95.12% and the bacterial clearance rate was 92.5%. Conclusion The efficacy of piperacillin / tazobactam in the treatment of acute exacerbation of chronic obstructive pulmonary disease is remarkable.